Company / Gross Profit per Share
Sunshine Biopharma Inc. Gross Profit per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$4.14
FY2025
5-year range
$0.03 / $595.14
FY2021-FY2025
Trend
-99.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.08 to $4.14 over the past 2 years.
Based on SEC 10-K filings.
4.14 in FY2025 with a 5-year CAGR of +579.7%.
Improved from $0.08 to $4.14 over the past 2 years.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +359.3%
- 5-Year CAGR
- +579.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, gross profit per share decreased 99.3% year-over-year.
- Peak gross profit per share was recorded in FY2024.
- Lowest gross profit per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.14 | -99.3% |
| FY2024 | $595.14 | +792185.9% |
| FY2023 | $0.08 | +76.0% |
| FY2022 | $0.04 | +62.3% |
| FY2021 | $0.03 | +9125.5% |
| FY2020 | $0.00 | - |
| FY2019 | $0.00 | - |
| FY2018 | $0.00 | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026